Impact Grant - Chordoma Foundation supports researchers pursuing preclinical and translational chordoma immunology projects to explore new immunotherapy approaches and accelerate research in this disease.
CRI Impact Grant supports researchers conducting clinically relevant chordoma research that bridges laboratory and clinical discovery to translate immunological findings into cancer immunotherapies.
Clinical Innovator Award supports researchers conducting early-phase immunotherapy trials in chordoma, funding clinical investigation to move promising concepts toward potential patient impact.
CRI Clinical Innovator supports academic researchers leading early-phase cancer immunotherapy trials to test novel treatments, study response mechanisms, and identify biomarkers to improve patient outcomes.
ASPIRE Award: TBXT and Beyond: Expanding the Chordoma Surfaceome supports researchers studying TBXT and other tumor-specific surface targets to enable surface-targeted therapies for chordoma.
Game Changer Grant supports researchers pursuing innovative, hypothesis-driven DIPG/DMG projects that address major challenges, seek groundbreaking discoveries, and advance the search for a cure.